Dow Considering Sale of Stake in Sadara Chemicals Amid Financial Strains
Dow Inc. is reportedly evaluating the sale of its 35% stake in Sadara Chemical, a $20 billion joint venture with Saudi Aramco, as part of broader portfolio restructuring efforts amid ongoing challenges in the global chemicals industry. The potential exit could alleviate financial pressure on Dow, which has recorded a negative investment balance and suspended recognition of equity losses from the venture. Sadara's operations have been affected by supply chain disruptions due to Middle East conflicts, compounding existing issues like weak demand and oversupply. Selling its stake in Sadara may allow Dow to redirect capital toward higher-return businesses while reducing future funding obligations tied to the joint venture. The company has aimed for free-cash-flow breakeven and is focused on cost reductions. While Saudi Aramco or another investor could potentially acquire the stake, concerns remain that selling during a downturn might mean sacrificing long-term strategic value in favor of short-term financial relief.
Tickers: $DOW
Topics: chemical industry downturn Dow joint venture exit Sadara Chemicals Saudi Aramco